# Nectar Lifesciences Limited – FDA Inspection, Mar 10, 2023

Source: https://www.keypedia.com/records/fda_inspections/nectar-lifesciences-limited/60d76fd7-7e2d-491f-a835-c718e18c3eaa
Source feed: FDA_Inspections

> FDA inspection 1200622 of Nectar Lifesciences Limited, March 10, 2023. Classification: Official Action Indicated (OAI). 14 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1200622
- Company Name: Nectar Lifesciences Limited
- Inspection Date: 2023-03-10
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 14

## Related Documents

- [FDA Inspection 865677 - 2014-01-21](https://www.keypedia.com/records/fda_inspections/nectar-lifesciences-limited/006c5dbe-e237-4591-9ab6-13da4a36c9b4)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/anastasia-m-shields/a22b8d52-e3f9-4e61-aa3f-6f03ff2f59df)
- [Investigator](https://www.keypedia.com/people/jeffrey-p-raimondi/7576ca4e-d9e8-4015-9ae6-9498e76058d3)

Company: https://www.keypedia.com/companies/nectar-lifesciences-limited/7b5dd8c8-0a38-4956-be6f-74871597ce80

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
